Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose Chemotherapy.

Anbil, Sriram; Pigula, Michael; Huang, Huang-Chiao; Mallidi, Srivalleesha; Broekgaarden, Mans; Baglo, Yan; De Silva, Pushpamali; Simeone, Diane M; Mino-Kenudson, Mari; Maytin, Edward V; Rizvi, Imran; Hasan, Tayyaba

Anbil, Sriram; Pigula, Michael; Huang, Huang-Chiao; Mallidi, Srivalleesha; Broekgaarden, Mans; Baglo, Yan; De Silva, Pushpamali; Simeone, Diane M; Mino-Kenudson, Mari; Maytin, Edward V; Rizvi, Imran; Hasan, Tayyaba.

Afiliación

Anbil S; Long School of Medicine, UT Health San Antonio, San Antonio, Texas.
Pigula M; Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Huang HC; Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Mallidi S; Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Broekgaarden M; Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Baglo Y; Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
De Silva P; Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Simeone DM; Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Mino-Kenudson M; Department of Surgery, Langone School of Medicine, New York University, New York, New York.
Maytin EV; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Rizvi I; Department of Dermatology and Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio.
Hasan T; Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Mol Cancer Ther ; 19(6): 1308-1319, 2020 06.

Article en En | MEDLINE | ID: mdl-32220968

Asunto(s)

Antineoplásicos/farmacología; Calcitriol/análogos & derivados; Carcinoma Ductal Pancreático/tratamiento farmacológico; Regulación Neoplásica de la Expresión Génica; Neoplasias Pancreáticas/tratamiento farmacológico; Fotoquimioterapia; Receptores de Calcitriol/metabolismo; Animales; Apoptosis; Biomarcadores de Tumor/genética; Biomarcadores de Tumor/metabolismo; Calcitriol/farmacología; Carcinoma Ductal Pancreático/metabolismo; Carcinoma Ductal Pancreático/patología; Carcinoma Ductal Pancreático/radioterapia; Proliferación Celular; Quimiocina CXCL12/genética; Quimiocina CXCL12/metabolismo; Fármacos Dermatológicos/farmacología; Humanos; Masculino; Ratones; Ratones Desnudos; Neoplasias Pancreáticas/metabolismo; Neoplasias Pancreáticas/patología; Neoplasias Pancreáticas/radioterapia; Receptores CXCR/genética; Receptores CXCR/metabolismo; Receptores CXCR4/genética; Receptores CXCR4/metabolismo; Receptores de Calcitriol/genética; Células Tumorales Cultivadas; Ensayos Antitumor por Modelo de Xenoinjerto

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Fotoquimioterapia / Calcitriol / Regulación Neoplásica de la Expresión Génica / Receptores de Calcitriol / Carcinoma Ductal Pancreático / Antineoplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Cancer Ther Año: 2020 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google